SCHEMBL9047458

SCHEMBL9047458

N#C[C@@H]1CSCN1C(=O)[C@@H]1NCCC1C(=O)C1=Cc2ccccc2C1

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PREP P48147 2/20 0.37
DPP4 P27487 6/20 0.33
FAP Q12884 3/20 0.32
DPP8 Q6V1X1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9047800 0.85 DPP4 (0.46) PREPDPP4FAPDPP8
SCHEMBL9049093 0.85 PREP (0.38) PREPDPP4FAPDPP8
SCHEMBL9048453 0.84 PREP (0.37) PREPDPP4FAP
SCHEMBL9167883 0.82
SCHEMBL9047451 0.82 PREP (0.35) PREPDPP4
SCHEMBL9051819 0.80 PREP (0.43) PREPDPP4FAPDPP8
SCHEMBL9049184 0.78 PREP (0.47) PREPDPP4
SCHEMBL9051117 0.78 PREP (0.49) PREPDPP4
SCHEMBL9050430 0.78 PREP (0.49) PREPDPP4
SCHEMBL9049641 0.77 PREP (0.44) PREPDPP4FAPDPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0536399-B1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARM CO LTD (JP) 1996-01-24 EP disclosed
US-5407950-A Brain disorders, senile dementia ZERIA PHARMACEUTICAL CO., LTD. (JP) 1995-04-18 US disclosed
EP-0536399-A1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARMACEUTICAL CO., LTD. (JP) 1993-04-14 EP disclosed